Amphiphilic macrocycles,
such as
p
-sulfonatocalix[6]arenes
(
p
-SC6), have demonstrated great potential in designing
synthetic nanovesicles based on self-assembly approaches. These supramolecular
nanovesicles are capable of improving the solubility, stability, and
biological activity of various drugs. In the present study, the biologically
active harmala alkaloid-rich fraction (HARF) was extracted from
Peganum harmala L
. seeds. Ultraperformance liquid
chromatography–electrospray ionization–tandem mass spectrometry
(UPLC/ESI-MS) analysis of HARF revealed 15 alkaloids. The reversed-phase
high-performance liquid chromatography (RP-HPLC) analysis revealed
three peaks: peganine, harmol, and harmine. The HARF was then encapsulated
in
p
-SC6 nanocapsules employing a thin-film hydration
approach. The designed nanocapsules had an average particle size of
264.8 ± 10.6 nm, and a surface charge of −30.3 ±
2.2 mV. They were able to encapsulate 89.3 ± 1.4, 74.4 ±
1.3, and 76.1 ± 1.7% of the three harmala alkaloids; harmine,
harmol, and peganine; respectively. The
in vitro
drug
release experiments showed the potential of the designed nanocapsules
to release their cargo at a pH of 5.5 (typical of cancerous tissue).
The IC
50
values of HARF encapsulated in
p
-SC6 (H/
p
-SC6 nanocapsules) were 5 and 2.7 μg/mL
against ovarian cancer cells (SKOV-3) and breast adenocarcinoma cells
(MCF-7), respectively. The prepared nanocapsules were found to be
biocompatible when tested on human skin fibroblasts. Additionally,
the antioxidant activity of the designed nanocapsules was 5 times
that of the free powder fraction; the IC
50
of the H/
p
-SC6 nanocapsules was 30.1 ± 1.3 μg/mL, and
that of the HARF was 169.3 ± 7.2 μg/mL. In conclusion,
encapsulation of
P. harmala
alkaloid-rich
fraction into self-assembled
p
-SC6 significantly
increases its antioxidant and cytotoxic activities.